Mirum Pharmaceuticals (MIRM) Projected to Announce Quarterly Earnings on ThursdayMarket Beat·Jul 23 at 02:26 AMMIRM+1.04%
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIRM Stock NewsStockTitan·Jul 13 at 07:01 AMMIRM+1.04%
Mirum SVP, Global Controller Jolanda Howe disposes of 2,721 common shares worth $326,520PUBT·Jul 2 at 05:01 PMMIRM+1.04%
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00 at JPMorgan Chase & Co.Market Beat·Jul 2 at 09:42 AMMIRM+1.04%
MIRM: Robust sales growth and a rich late-stage pipeline position the company for five potential approvals by 2027Quartr·Jul 1 at 05:24 PMMIRM+1.04%
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & Morerttnews·Jun 29 at 03:19 AMMIRM+1.04%TWST-4.13%
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month High - Should You Buy?Market Beat·Jun 24 at 01:00 PMMIRM+1.04%
Mirum SVP, Global Controller Jolanda Howe sells 2,594 shares for $264,458.3PUBT·Jun 18 at 05:40 PMMIRM+1.04%
Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva | INCY Stock NewsStockTitan·Jun 14 at 07:35 AMINCY+1.02%MIRM+1.04%
